Nanomedicine and Nanotechnology
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
”Nanomedicine and Nanotechnology” is a new section of the peer-reviewed open access journal Pharmaceutics, which is focused on all aspects and applications of innovative nanosystems.
The main aims of this section are to highlight and collect recent progress in nanotechnology and its applications in pharmaceutical, clinical, diagnostic, environmental, and cosmetic fields.
Covered topics include the following:
- Advances in methodologies for characterization of nanocarriers
- Nanodevices and nanosensors
- Stability studies
- Development of new drug delivery systems
- Nanotoxicity
- Skin and mucosal application
- Nanotechnology in tissue engineering and regenerative nanomedicine
- Functionalization for a selective target
- Nanodelivery systems in cosmeceutical and nutraceutical field
- Nanodelivery as a strategy to improve bioavailability
- Strategies and formulations for controlled drug release
- In vivo testing
The section encourages the submission of papers including in vitro and in vivo evidence and clinical data on nanomedicine and nanotechnology fields. Authors will enjoy a high-quality reviewing process, rapid publication, and high visibility from access to a broad readership.
Review, original research papers, communications, short communications, opinions, or technical notes will be considered for publication.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Developments in Theranostic Nanoparticulate Drug Delivery Systems (Deadline: 20 January 2021)
- Development of Micro and Nano Systems for the Drug Delivery (Deadline: 31 January 2021)
- Lipid and Polymeric Based Antibiotic Nanosystems (Deadline: 31 January 2021)
- Remotely Controlled Nanomedicines for Precision Medicine (Deadline: 20 February 2021)
- Recent Advances in Drug Based Nanosystems for Cancer Therapy (Deadline: 20 February 2021)
- Nanomedicine across Barriers (Deadline: 25 February 2021)
- Non-invasive Drug, Protein and Gene Delivery Systems: Current Progress and Future Prospects (Deadline: 28 February 2021)
- Novel Nanoparticle-Based Treatment and Imaging Modalities (Deadline: 1 March 2021)
- Solid Lipid Nanoparticles in the Treatment of Neurological Diseases (Deadline: 10 March 2021)
- Protein-based Nanoparticles for Drug Delivery (Deadline: 10 March 2021)
- Applied Nanotechnology in Chronic Human Disease Management (Deadline: 31 March 2021)
- Preclinical Evaluation of Lipid-Based Nanosystems (Deadline: 31 March 2021)
- Nanotechnology-Based Approaches for Enhancing Oral Administration of Drugs (Deadline: 31 March 2021)
- Up-to-Date Pharmaceutical Applications of Micro/Nanoemulsions (Deadline: 31 March 2021)
- Site Specific Delivery of Biomolecules Using Conjugated Macromolecules and Nanocarriers (Deadline: 31 March 2021)
- Lipid-based Nanoparticle Systems for Drug Delivery (Deadline: 31 March 2021)
- Anticancer Nanomedicine: Recent Advances (Deadline: 31 March 2021)
- Nanomaterials for Cancer Photothermal Therapy (Deadline: 31 March 2021)
- Biopolymer Materials for Wound Healing (Deadline: 10 April 2021)
- Biomimetic and Functional Nanomaterials for Molecular Imaging (Deadline: 15 April 2021)
- Biomimetic Magnetic Nanoparticles for Cancer Therapy (Deadline: 20 April 2021)
- Polymer Therapeutics: From Synthesis to Biomedical Applications (Deadline: 20 April 2021)
- Advances in Stimuli-Responsive Tumor Targeting Nanotechnology (Deadline: 30 April 2021)
- Advanced Polymeric-Based Nanocarriers for Drug Delivery and Theranosis (Deadline: 30 April 2021)
- Radionanomedicine: Synergistic Relation between Nuclear and Nanomedicine (Deadline: 20 May 2021)
- Application of Drug Penetration or Delivery in the Fight Against Infectious Diseases (Deadline: 20 May 2021)
- Polymeric Nanocapsules in Drug Delivery (Deadline: 20 May 2021)
- Application of Gold Nanoparticles and Gold-Based Polymer Composites in Biomedicine (Deadline: 20 May 2021)
- Advanced Nanoscience of Biomaterials for Biomedical Applications (Deadline: 30 May 2021)
- Polymeric Nanoparticles Applied to Therapy and Diagnostics (Deadline: 31 May 2021)
- Functional Polymeric Nanoparticles for Enhanced Cancer Therapy (Deadline: 31 May 2021)
- Drug Nanocrystals (Deadline: 31 May 2021)
- Nanocarriers for Drug Delivery and/or Gene Therapy in Cancer (Deadline: 10 June 2021)
- Nanomedicine as a Tool to Improve the Local Delivery of Active Molecules (Deadline: 20 June 2021)
- Novel Drug Delivery Nanosystems for Cancer Therapy and Bio-Regeneration (Deadline: 30 June 2021)
- Overcoming Physiological Barriers Using Lipid Nanosystems (Deadline: 30 June 2021)
- At the Interface of Life and Nanomaterials: From Pharmaceutics to other Related Areas (Deadline: 30 June 2021)
- Nanogels and Nanoparticles for Selective Drug Delivery (Deadline: 30 June 2021)
- Encapsulation of Single or Multiple Molecules in Nano- and Microparticles for Drug Delivery (Deadline: 30 June 2021)
- Nanomedicines for Advanced Treatment and Diagnosis of Inflammation (Deadline: 20 July 2021)
- Stimuli-Responsive Nanomedicine as New Generation Therapeutic Agents (Deadline: 30 July 2021)
- Sophisticated Nanostructures for Advanced Drug Delivery (Deadline: 31 August 2021)
- Cancer Nanomedicine—From the Bench to the Bedside (Deadline: 31 August 2021)
- Stimuli-Responsive Nanomedicine for the Effective and Controlled Delivery of Drug Molecules to the Tumor Microenvironment (Deadline: 31 August 2021)
- Nanomaterials for Clinical Translation (Deadline: 30 September 2021)
- Nanomedicine and Thrombolytics – Present and Future Partnership to Overcome Thrombotic Related Diseases (Deadline: 30 October 2021)
- Nanoparticle Delivery to Tumors: Challenges and Advances (Deadline: 31 December 2021)
